4 results match your criteria: "Mihama Sakura Clinic[Affiliation]"
Modeling Low Muscle Mass Screening in Hemodialysis Patients.
Nephron
May 2023
Fujidera Keijin-kai Clinic, Fujidera, Japan.
Introduction: Computed tomography (CT) can accurately measure muscle mass, which is necessary for diagnosing sarcopenia, even in dialysis patients. However, CT-based screening for such patients is challenging, especially considering the availability of equipment within dialysis facilities. We therefore aimed to develop a bedside prediction model for low muscle mass, defined by the psoas muscle mass index (PMI) from CT measurement.
View Article and Find Full Text PDFThe Role of Cardio-Ankle Vascular Index as a Predictor of Mortality in Patients on Maintenance Hemodialysis.
Vasc Health Risk Manag
December 2021
Seijinkai Mihama Hospital, Chiba City, Chiba, 261-0013, Japan.
Article Synopsis
- The study aimed to explore the relationship between cardio-ankle vascular index (CAVI) and mortality in maintenance hemodialysis patients, as well as the impact of age and nutrition on patient survival.
- Researchers monitored 242 hemodialysis patients over 6 years, analyzing data from 209 patients while measuring CAVI and heart to ankle pulse wave velocity (haPWV).
- Findings indicated that higher CAVI and haPWV, along with older age and poorer nutritional markers, were linked to increased mortality; CAVI showed superior predictive power for mortality compared to haPWV, suggesting it may be a key modifiable risk factor.
Importance of isolated anti-hbc in detection of occult hepatitis B virus infection in hemodialysis patients: reply.
Ther Apher Dial
December 2013
Mihama Hospital, Sakura, Chiba, Japan; Mihama Sakura Clinic, Sakura, Chiba, Japan.
Occult hepatitis B virus infection in Japanese chronic hemodialysis patients.
Ther Apher Dial
June 2013
Mihama Sakura Clinic, 602-1 Shimosizu, Sakura, Chiba 285-0841, Japan.
We investigated the prevalence of occult hepatitis B virus (HBV) infection in Japanese chronic hemodialysis patients. Hemodialysis patients (n = 1041) were screened for occult HBV. The presence of hepatitis B surface antigen (HBsAg), hepatitis B surface antibody, and hepatitis B core antibody (anti-HBc) was determined by various chemiluminescent immunoassays.
View Article and Find Full Text PDF